Centessa Pharmaceuticals Plc (CNTA)
39.45
-0.01
(-0.03%)
USD |
NASDAQ |
Apr 29, 16:00
41.95
+2.50
(+6.34%)
After-Hours: 07:54
Centessa Pharmaceuticals EPS Diluted (Quarterly) : -0.4717 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Eli Lilly & Co. | 7.024 |
| Apellis Pharmaceuticals, Inc. | -0.4654 |
| Roivant Sciences Ltd. | -0.3816 |
| Silence Therapeutics Plc | -0.0831 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -66.07M |
| Total Expenses (Quarterly) | 66.07M |
| Enterprise Value | 5.925B |
| Earnings Yield | -3.69% |
| Normalized Earnings Yield | -3.754 |